ANGELIA HONORA: Open Payments
NPI 1730519356 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 27 payments from 11 companies in 2025. Trend: 2023 $812 · 2024 $674 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $188 |
| Novo Nordisk Inc | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Gilead Sciences, Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Exact Sciences Corporation | 3 | $49 |
| Dexcom, Inc. | 2 | $47 |
| Abbott Laboratories | 1 | $27 |
| Lilly USA, LLC | 1 | $17 |
Products named: AIRSUPRA, Ozempic, LEQVIO, Kerendia, BREZTRI, TRELEGY ELLIPTA, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
